Literature DB >> 7665666

Comparison of three methods for culturing throat swabs from cystic fibrosis patients.

J E Hoppe1, U Theurer-Mainka, M Stern.   

Abstract

In patients with cystic fibrosis who do not produce sputum, deep throat swabs are cultured for potential respiratory pathogens. Usually these swabs are directly streaked onto selective agar media. In a study of 50 pediatric cystic fibrosis patients, we compared this traditional method using rayon swabs with two methods having quantitative modifications: calcium alginate swabs eluted in Ringer's lactate and rayon swabs eluted in normal saline. The eluates were then processed quantitatively (three-step dilution series). The yield of potential pathogens was significantly higher with the two quantitative methods. Overall, the combination of alginate with Ringer's lactate was superior to the combination of rayon with saline, although only some of these differences achieved statistical significance.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7665666      PMCID: PMC228293          DOI: 10.1128/jcm.33.7.1896-1898.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  4 in total

1.  The isolation of Streptococcus pyogenes from throat swabs.

Authors:  P W Ross
Journal:  J Med Microbiol       Date:  1977-02       Impact factor: 2.472

2.  Recovery of Bordetella pertussis from four kinds of swabs.

Authors:  J E Hoppe; A Weiss
Journal:  Eur J Clin Microbiol       Date:  1987-04       Impact factor: 3.267

Review 3.  Microbiology of airway disease in patients with cystic fibrosis.

Authors:  P H Gilligan
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

4.  Optimum use of selective plated media in primary processing of respiratory tract specimens from patients with cystic fibrosis.

Authors:  G V Doern; B Brogden-Torres
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

  4 in total
  4 in total

1.  Inoculum size influences bacterial cross contamination between surfaces.

Authors:  R Montville; D W Schaffner
Journal:  Appl Environ Microbiol       Date:  2003-12       Impact factor: 4.792

2.  Tobramycin once- vs thrice-daily for elective intravenous antipseudomonal therapy in pediatric cystic fibrosis patients.

Authors:  J Riethmueller; M Ballmann; T W Schroeter; P Franke; R von Butler; A Claass; S Junge; G Doering; M Stern
Journal:  Infection       Date:  2009-09-05       Impact factor: 3.553

3.  Continuous vs thrice-daily ceftazidime for elective intravenous antipseudomonal therapy in cystic fibrosis.

Authors:  J Riethmueller; S Junge; T W Schroeter; K Kuemmerer; P Franke; M Ballmann; A Claass; S Broemme; R Jeschke; A Hebestreit; D Staab; K Koetz; G Doering; M Stern
Journal:  Infection       Date:  2009-09-05       Impact factor: 3.553

4.  Characterization and quantification of the fungal microbiome in serial samples from individuals with cystic fibrosis.

Authors:  Sven D Willger; Sharon L Grim; Emily L Dolben; Anna Shipunova; Thomas H Hampton; Hilary G Morrison; Laura M Filkins; George A O'Toole; Lisa A Moulton; Alix Ashare; Mitchell L Sogin; Deborah A Hogan
Journal:  Microbiome       Date:  2014-11-03       Impact factor: 14.650

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.